Private practice in Taipei, Taiwan.
Aesthet Surg J. 2019 Jan 1;39(1):41-52. doi: 10.1093/asj/sjy030.
Cell-assisted lipotransfer (CAL) has been considered a promising technique for promoting adipogenesis and angiogenesis in fat grafts.
The author sought to objectively analyze the change of breast volume in patients who underwent stromal vascular fraction (SVF)-enriched fat grafting for breast augmentation and compared the clinical results with those who underwent conventional fat grafting without SVF by using 3-dimensional laser scanning.
From April 2015 to March 2016, 105 patients who underwent traditional fat grafting without SVF enrichment for breast augmentation were assigned to group A and served as the control. The other 101 patients who underwent SVF-enriched fat grafting for breast augmentation were assigned to group B. The charts of these patients were retrospectively reviewed.
The survival rate of the transplanted fat was 67.9% in group A and 68.7% in group B at 12 months after the operation. Postoperative complication rate was 3.8% in group A and 5.9% in group B. The differences were statistically insignificant.
SVF does not ensure a higher survival rate in autologous fat grafting for breast augmentation. Considering the potential drawbacks of adipose-derived stem cells (ADSC) and the extra cost of the consumables, in particular the need for harvesting larger amount of fat which could be reserved for additional fat grafting at a later time to achieve even better improvement, the results of this study do not support the use of SVF in autologous fat grafting for breast augmentation in terms of graft survival and postoperative complications.
细胞辅助脂肪转移(CAL)被认为是促进脂肪移植物中脂肪生成和血管生成的有前途的技术。
作者试图通过三维激光扫描客观分析接受富含基质血管成分(SVF)的脂肪移植进行乳房增大的患者乳房体积的变化,并将其与未接受 SVF 的常规脂肪移植的临床结果进行比较。
2015 年 4 月至 2016 年 3 月,将 105 例接受传统的无 SVF 富集的脂肪移植进行乳房增大的患者分为 A 组作为对照组。另外 101 例接受 SVF 富集的脂肪移植进行乳房增大的患者分为 B 组。回顾性分析这些患者的图表。
A 组术后 12 个月移植脂肪的存活率为 67.9%,B 组为 68.7%。A 组术后并发症发生率为 3.8%,B 组为 5.9%。差异无统计学意义。
SVF 并不能保证自体脂肪移植隆胸的存活率更高。考虑到脂肪源性干细胞(ADSC)的潜在缺点和耗材的额外成本,特别是需要采集更多的脂肪,以便以后再进行额外的脂肪移植以获得更好的改善效果,因此就移植存活率和术后并发症而言,本研究的结果不支持在自体脂肪移植隆胸中使用 SVF。